基本信息
浏览量:251
职业迁徙
个人简介
Also at Johns Hopkins, Dr. Hammers led the kidney cancer research efforts and played a major role in the development of immunotherapy with immune checkpoint inhibitors in kidney cancer. His work in immunotherapy has been nationally recognized, and he has been the principal investigator on several industry- and investigator-sponsored trials.
Dr. Hammers joined the UT Southwestern faculty in 2016. He is co-leader of clinical research and immunotherapy for the kidney cancer research program and will be continuing his research efforts to develop novel immunotherapies for kidney cancer.
Immunotherapy Expert
Dr. Hammers is an international thought leader in immunotherapy, a form of treatment that boosts the body’s own immune defenses to help fight cancer – and one that is changing the kidney cancer landscape.
His goal is to continue to develop and improve innovative immunotherapies for kidney cancer and provide access to them for UT Southwestern patients.
“Immunotherapy holds curative potential. It’s a real game changer in oncology, and UT Southwestern is helping to lead the way in the development of new treatments for kidney cancer patients,” Dr. Hammers says.
Dr. Hammers joined the UT Southwestern faculty in 2016. He is co-leader of clinical research and immunotherapy for the kidney cancer research program and will be continuing his research efforts to develop novel immunotherapies for kidney cancer.
Immunotherapy Expert
Dr. Hammers is an international thought leader in immunotherapy, a form of treatment that boosts the body’s own immune defenses to help fight cancer – and one that is changing the kidney cancer landscape.
His goal is to continue to develop and improve innovative immunotherapies for kidney cancer and provide access to them for UT Southwestern patients.
“Immunotherapy holds curative potential. It’s a real game changer in oncology, and UT Southwestern is helping to lead the way in the development of new treatments for kidney cancer patients,” Dr. Hammers says.
研究兴趣
论文共 355 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal for ImmunoTherapy of Cancerno. 4 (2024)
Lucía Carril-Ajuria, Pernelle Lavaud,Cecile Dalban, Sylvie Negrier,Gwénaëlle Gravis, Robert J. Motzer,Christine Chevreau, Nizar M. Tannir,Stéphane Oudard, David F. McDermott, Brigitte Laguerre,Hans J. Hammers,
The New England journal of medicineno. 15 (2024): 1359-1371
Journal for immunotherapy of cancerno. 4 (2024)
Michael B Atkins,Opeyemi A Jegede,Naomi B Haas,David F Mcdermott, Mehmet A Bilen,Mark Stein,Jeffrey Sosman,Robert Alter,Elizabeth R Plimack,Moshe C Ornstein,Michael Hurwitz, David J Peace,
Journal for ImmunoTherapy of Cancerno. 4 (2024)
Scientific Reportsno. 1 (2024): 708-708
Pedro Barata, Shuchi Gulati,Andrew Elliott, Hans J Hammers,Earle F Burgess, Benjamin A Gartrell,Sourat Darabi, Mehmet A Bilen,Arnab Basu, Daniel M Geynisman, Nancy A Dawson,Matthew R Zibelman,
The Journal of clinical investigation (2024)
Judy S. Wang,Manish R. Sharma, William J. Edenfield,Kartik Sehgal,Do-Youn Oh, Yixing Jiang, Joel Michalski, Jeeyun Lee,Hans Hammers,Li-Yuan Bai,Chih-Hung Hsu, Brenda Dampier,
Cancer Researchno. 7_Supplement (2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn